Blood pressure, cholesterol and cardiovascular disease in Thailand

Panrasri Khonputsa1, J Lennert Veerman2, Prin Vathesatogkit3

  • 1The Setting Priorities using Information on Cost-Effectiveness Project, Ministry of Public Health, Nonthaburi Thailand; The University of Queensland, School of Population Health, Brisbane, QLD Australia.

Heart Asia
|June 22, 2016
PubMed

Insights

Systolic blood pressure and total cholesterol significantly increase risks for ischaemic heart disease and stroke in Thailand. These associations are comparable to those found in other global populations, highlighting universal risk factors for cardiovascular disease.

Area of Science:

  • Epidemiology
  • Cardiovascular Disease Research
  • Public Health

Background:

  • Established associations between hypertension, hypercholesterolemia, and cardiovascular disease (CVD).
  • Limited understanding of ethnic and regional variations in these CVD risk factor associations.
  • Need to assess risk factor contributions in diverse populations.

Purpose of the Study:

  • To quantify the impact of systolic blood pressure (SBP) and total cholesterol (TC) on ischaemic heart disease (IHD) and stroke risk within the Thai population.
  • To compare these associations with findings from other global regions.

Main Methods:

  • Analysis of data from a Thai cohort study (2702 males, 797 females, aged 35-54 at baseline).
  • Utilized Cox Proportional Hazards Models to assess relative risks (RRs) of IHD and stroke.
  • Stratified analyses by age groups (30-44, 45-59, 60-69 years) at the time of event over 17 years of follow-up.

Main Results:

  • A 1 mmol/l increase in TC was linked to a fivefold higher IHD risk in the 30-44 age group.
  • SBP increases showed significant associations with IHD and stroke risk across older age groups (45-59 and 60-69 years).
  • Specific RRs for SBP increases were 1.31-1.46 for IHD and 1.40-1.85 for stroke, depending on age.

Conclusions:

  • The observed increases in IHD and stroke risks associated with SBP and TC in Thailand are comparable to those reported in Asia Pacific and Western populations.
  • These findings underscore the universal nature of these cardiovascular risk factors across different ethnicities and regions.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
762
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.7K
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
7.6K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
813
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
567
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
821